Literature DB >> 21651996

Nanofibrillated cellulose composite hydrogel for the replacement of the nucleus pulposus.

Ana C Borges1, Christian Eyholzer, Fabien Duc, Pierre-Etienne Bourban, Philippe Tingaut, Tanja Zimmermann, Dominique P Pioletti, Jan-Anders E Månson.   

Abstract

The swelling and compressive mechanical behavior as well as the morphology and biocompatibility of composite hydrogels based on Tween® 20 trimethacrylate (T3), N-vinyl-2-pyrrolidone (NVP) and nanofibrillated cellulose (NFC) were assessed in the present study. The chemical structure of T3 was verified by Fourier transform infrared spectroscopy and proton nuclear magnetic resonance, and the degree of substitution was found to be around 3. Swelling ratios of neat hydrogels composed of different concentrations of T3 and NVP were found to range from 1.5 to 5.7 with decreasing concentration of T3. Various concentrations of cellulose nanofibrils (0.2-1.6wt.%) were then used to produce composite hydrogels that showed lower swelling ratios than neat ones for a given T3 concentration. Neat and composite hydrogels exhibited a typical nonlinear response under compression. All composite hydrogels showed an increase in elastic modulus compared to neat hydrogel of about 3- to 8-fold, reaching 18kPa at 0% strain and 62kPa at 20% strain for the hydrogel with the highest NFC content. All hydrogels presented a porous and homogeneous structure, with interconnected pore cells of around 100nm in diameter. The hydrogels are biocompatible. The results of this study demonstrate that composite hydrogels reinforced with NFC may be viable as nucleus pulposus implants due to their adequate swelling ratio, which may restore the annulus fibrosus loading, and their increased mechanical properties, which could possibly restore the height of the intervertebral discs.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651996     DOI: 10.1016/j.actbio.2011.05.029

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  5 in total

1.  Characterization of injectable hydrogels based on poly(N-isopropylacrylamide)-g-chondroitin sulfate with adhesive properties for nucleus pulposus tissue engineering.

Authors:  Craig Wiltsey; Pamela Kubinski; Thomas Christiani; Katelynn Toomer; Joseph Sheehan; Amanda Branda; Jennifer Kadlowec; Cristina Iftode; Jennifer Vernengo
Journal:  J Mater Sci Mater Med       Date:  2013-01-31       Impact factor: 3.896

2.  The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells.

Authors:  Yan-Ru Lou; Liisa Kanninen; Tytti Kuisma; Johanna Niklander; Luke A Noon; Deborah Burks; Arto Urtti; Marjo Yliperttula
Journal:  Stem Cells Dev       Date:  2013-12-09       Impact factor: 3.272

3.  Preparation of photocrosslinked fish elastin polypeptide/microfibrillated cellulose composite gels with elastic properties for biomaterial applications.

Authors:  Shinya Yano; Megumi Mori; Naozumi Teramoto; Makoto Iisaka; Natsumi Suzuki; Masanari Noto; Yasuko Kaimoto; Masashi Kakimoto; Michio Yamada; Eri Shiratsuchi; Toshiaki Shimasaki; Mitsuhiro Shibata
Journal:  Mar Drugs       Date:  2015-01-09       Impact factor: 5.118

Review 4.  Current State of Applications of Nanocellulose in Flexible Energy and Electronic Devices.

Authors:  Otavio Augusto Titton Dias; Samir Konar; Alcides Lopes Leão; Weimin Yang; Jimi Tjong; Mohini Sain
Journal:  Front Chem       Date:  2020-05-21       Impact factor: 5.221

5.  Development of Bioinspired Functional Chitosan/Cellulose Nanofiber 3D Hydrogel Constructs by 3D Printing for Application in the Engineering of Mechanically Demanding Tissues.

Authors:  Arnaud Kamdem Tamo; Ingo Doench; Lukas Walter; Alexandra Montembault; Guillaume Sudre; Laurent David; Aliuska Morales-Helguera; Mischa Selig; Bernd Rolauffs; Anke Bernstein; Daniel Hoenders; Andreas Walther; Anayancy Osorio-Madrazo
Journal:  Polymers (Basel)       Date:  2021-05-20       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.